Cooper Companies, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
The Cooper Companies reported a 5% increase in fiscal year 2025 net sales to $4.09 billion, driven by CooperVision, but saw a 3% decline in operating income and a 63% drop in CooperSurgical's operating income.
NASDAQ
10-K: Cooper Companies Reports Fiscal Year 2024 Results Amidst Global Expansion and Market Challenges
The Cooper Companies, a global medical device company, released its 10-K filing for fiscal year 2024, highlighting growth in both its CooperVision and CooperSurgical segments while navigating economic and regulatory complexities.